DP-QB-STA-005

AXP000243.1 · Phage therapy

Platform
phage cocktail (five phages)
Sponsor
Ottawa Hospital Research Institute

Names

NameTypeSource
DP-QB-STA-005preferred name, codecurator, ctgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
Staphylococcus aureus bacteriophage (five-phage cocktail)
Replication
replicating
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07698002"Debridement PhagE AnTibiotics for PJI"Not yet recruitingPhase 2/32026-07-022027-08-0110Periprosthetic Infection

Recent changes

No changes recorded in its trials yet.

Notes

Five-phage cocktail against Staphylococcus aureus, used with DP-QB-PSA-005 in the phase 2/3 periprosthetic joint infection trial NCT07698002.

How to cite

DP-QB-STA-005 (AXP000243.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000243.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.